Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122232) titled 'Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria' on Aug. 7.
Study Type: Observational
Primary Sponsor: Rafiullah Hotak
Condition:
Malaria
Plasmodium Vivax Infection
Plasmodium Falciparum Infection
Thrombocytopenia
Recruitment Status: Not recruiting
Date of First Enrollment: April 1, 2023
Target Sample Size: 177
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122232
Published by HT Digital Content Services with permission from Health Daily Digest....